Literature DB >> 15708077

Can mycoplasma-mediated oncogenesis be responsible for formation of conventional renal cell carcinoma?

Mustafa Pehlivan1, Sacide Pehlivan, Huseyin Onay, Meral Koyuncuoglu, Ziya Kirkali.   

Abstract

OBJECTIVES: To investigate the association between Mycoplasma sp. infection and conventional renal cell carcinoma (RCC).
METHODS: Normal kidney, renal intratubular neoplasia, and tumor tissue samples from 33 patients with RCC and 35 healthy controls were studied. Molecular DNA analysis was done after nested polymerase chain reaction performed in two steps with seven primers (four outer and three inner) that can recognize at least 15 different Mycoplasma sp.
RESULTS: Mycoplasma sp. DNA was detected in normal kidney, renal intratubular neoplasia, and tumor tissue samples at a ratio of 36%, 67%, and 82%, respectively. In 6 of the 33 patients with RCC, no Mycoplasma sp. was detected from any of the three tissue samples. Mycoplasma sp. DNA was detected in only 5 (14%) of the 35 samples from the control group.
CONCLUSIONS: The relationship between mycoplasma infection and conventional RCC has been investigated for the first time, and a significantly high existence of Mycoplasma sp. DNA was found in the tissues of patients with conventional RCC compared with that found in a healthy control group. This suggests that mycoplasma-mediated multistage carcinogenesis may play a role in the development of RCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708077     DOI: 10.1016/j.urology.2004.10.015

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

Review 1.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

Review 2.  Intratumor microbiome in cancer progression: current developments, challenges and future trends.

Authors:  Jinyan Liu; Yi Zhang
Journal:  Biomark Res       Date:  2022-05-31

3.  Nucleic acid aptamer controls mycoplasma infection for inhibiting the malignancy of esophageal squamous cell carcinoma.

Authors:  Yibin Zhang; Hui Zhang; Xing Sun; Tianhuan Peng; Tiantian Xie; Yijun Yuan; Junxiao Guo; Yinglei Chen; Lingli Zhou; Neng Ling; Hui Li; Ling Li; Lin Zhang; Xiaodong Li; Long Liang; Jing Liu; Mao Ye; Weihong Tan
Journal:  Mol Ther       Date:  2022-02-18       Impact factor: 12.910

4.  Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells.

Authors:  Hua Yang; Like Qu; Huachong Ma; Ling Chen; Wenbin Liu; Caiyun Liu; Lin Meng; Jian Wu; Chengchao Shou
Journal:  BMC Gastroenterol       Date:  2010-11-10       Impact factor: 3.067

5.  Can mycoplasma contribute to formation of prostate cancer?

Authors:  Sakip M Erturhan; Omer Bayrak; Sacide Pehlivan; Hanifi Ozgul; Ilker Seckiner; Tugce Sever; Metin Karakök
Journal:  Int Urol Nephrol       Date:  2012-09-23       Impact factor: 2.370

6.  Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.

Authors:  Johan Vande Voorde; Suna Sabuncuoğlu; Sam Noppen; Anders Hofer; Farahnaz Ranjbarian; Steffen Fieuws; Jan Balzarini; Sandra Liekens
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

7.  Association of Mycoplasma hominis infection with prostate cancer.

Authors:  Yulia A Barykova; Denis Yu Logunov; Maxim M Shmarov; Andrei Z Vinarov; Dmitry N Fiev; Natalia A Vinarova; Irina V Rakovskaya; Patricia Stanhope Baker; Inna Shyshynova; Andrew J Stephenson; Eric A Klein; Boris S Naroditsky; Alexander L Gintsburg; Andrei V Gudkov
Journal:  Oncotarget       Date:  2011-04

8.  Mycoplasma and cancer: in search of the link.

Authors:  Melissa B Rogers
Journal:  Oncotarget       Date:  2011-04

9.  Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs.

Authors:  Johan Vande Voorde; Peter Vervaeke; Sandra Liekens; Jan Balzarini
Journal:  FEBS Open Bio       Date:  2015-08-03       Impact factor: 2.693

Review 10.  Mycoplasmas and cancer: focus on nucleoside metabolism.

Authors:  Johan Vande Voorde; Jan Balzarini; Sandra Liekens
Journal:  EXCLI J       Date:  2014-03-27       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.